Sandra J. Hofstead - Concepedia

Author

Sandra J. Hofstead

Also Known As

S J Hofstead, S. Hofstead, S. J. HOFSTEAD, S.J. Hofstead, SANDRA J. HOFSTEAD, Sandra Hofstead, Sandra J Hofstead, Sandra J. Hofstead

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Bristol-Myers Squibb (Germany)

About

Sandra J. Hofstead is an author at Bristol-Myers Squibb (United States) specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.7K
2	Biochemistry	6	6	693
3	Natural Sciences	5	5	673
4	Chemical Biology	4	4	623
5	Engineering	2	2	157

Sandra J. Hofstead

Publications

Citations

H-Index

Page 1

	Year	Citations
Cure of Xenografted Human Carcinomas by BR96-Doxorubicin Immunoconjugates Pamela A. Trail, David Willner, Shirley J. Lasch, Science Tumor BiologyCancer ImmunosurveillanceLewis YMedicineImmunology	1993	550
Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer Activity Gene M. Dubowchik, Raymond A. Firestone, Linda Padilla, Bioconjugate Chemistry Immunocytochemical TechniqueGlycobiologyImmunologyAntigen ProcessingImmunotherapy	2002	535
(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin David Willner, Pamela A. Trail, Sandra J. Hofstead, Bioconjugate Chemistry Pharmaceutical ScienceBioorganic ChemistryImmunologyChemical BiologyPharmaceutical Chemistry	1993	222
Kedarcidin, a new chromoprotein antitumor antibiotic: structure elucidation of kedarcidin chromophore John E. Leet, Daniel R. Schroeder, Sandra J. Hofstead, Journal of the American Chemical Society Pharmaceutical ScienceAltmetric Attention ScoreAntimicrobial ChemotherapyNew ChromoproteinChemical Biology	1992	160
Monoclonal Antibody Conjugates of Doxorubicin Prepared with Branched Peptide Linkers: Inhibition of Aggregation by Methoxytriethyleneglycol Chains Dalton King, Gene M. Dubowchik, Harold Mastalerz, Journal of Medicinal Chemistry Peptide EngineeringImmunologyMolecular BiologyPeptide ScienceChemical Biology	2002	134
Chemistry and structure elucidation of the kedarcidin chromophore John E. Leet, Daniel R. Schroeder, David R. Langley, Journal of the American Chemical Society Molecular SciencesEngineeringChemical MeasurementBiochemistryChemical Analysis	1993	107
Kedarcidin, a new chromoprotein antitumor antibiotic. II. Isolation, purification and physico-chemical properties. Sandra J. Hofstead, James A. Matson, Alison R. Malacko, The Journal of Antibiotics	1992	67
Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. Pamela A. Trail, David Willner, Jay O. Knipe, PubMed ImmunologyImmunotherapyTumor BiologyTumor ImmunologyOncology	1997	56
Purification, cloning, and functional expression of phenylalanine aminomutase: The first committed step in Taxol side-chain biosynthesis Christopher L. Steele, Yijun Chen, Brian Dougherty, Archives of Biochemistry and Biophysics BiosynthesisPhenylalanine AminomutaseEngineeringBiochemistryFunctional Expression	2005	50
Targeting the MraY and MurG bacterial enzymes for antimicrobial therapeutic intervention Laura E. Zawadzke, Ping Wu, Lynda Cook, Analytical Biochemistry AntibioticsMurg Bacterial EnzymesMedicineAntimicrobial Therapeutic InterventionAntibacterial Agent	2003	48

Page 1